⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TLSI News
TriSalus Life Sciences, Inc. Common Stock
TriSalus Life Sciences Reports Fourth Quarter and Year-End 2025 Results and Reaffirms 2026 Revenue Guidance
businesswire.com
TLSI
TriSalus Life Sciences to Host Fourth Quarter 2025 Financial Results Conference Call
businesswire.com
TLSI
Form 8-K
sec.gov
TLSI
TLSIW
TriSalus Life Sciences Announces Pricing of $40.0 Million Public Offering
businesswire.com
TLSI
TriSalus Life Sciences Announces Pricing of $40.0 Million Public Offering
businesswire.com
TLSI
TriSalus Life Sciences Proposes Public Offering
businesswire.com
TLSI
TriSalus Life Sciences Appoints Veteran Healthcare Investor Michael Stansky to its Board of Directors
businesswire.com
TLSI
The Light System Wraps Three-Day Miami Event 'Becoming Superhuman' Focused on Wellness and Human Potential
accessnewswire.com
TLSI
KBRA Assigns Preliminary Ratings to EFMT 2026-NQM1
businesswire.com
TLSI
TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Symptomatic Thyroid Disease on December 15, 2025
businesswire.com
TLSI